Status:
RECRUITING
Research Project on Reminders and Self-Sampling Can Increase Participation in Gynecology Cell Sampling - Preventive Examination Against Cervical Cancer.
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
Region Skane
Conditions:
Cervical Cancer
Uterine Cervical Neoplasm
Eligibility:
FEMALE
33-75 years
Phase:
NA
Brief Summary
Prevention of cervical cancer with cervical screening is one of the most successful screening activities in medicine. In Sweden, screening was implemented in the 1960s and has since prevented tens of ...
Detailed Description
Non-participation in the cervical screening program and sub-optimal follow-up after abnormalities or infection with a highly oncogenic HPV type detected in screening are the main risk factors for cerv...
Eligibility Criteria
Inclusion
- Women resident in Region Skane who either: 1) have had glandular cell transformation that has not been followed-up, 2) are older than 65 years and have had cell transformation that has not been followed-up or who have not participated in screening during the last 10 years, 3) women who have not been screened for more than 15 years.
Exclusion
- No exclusion except those who do not consent.
Key Trial Info
Start Date :
August 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2030
Estimated Enrollment :
20000 Patients enrolled
Trial Details
Trial ID
NCT04061967
Start Date
August 19 2019
End Date
June 1 2030
Last Update
January 14 2025
Active Locations (6)
Enter a location and click search to find clinical trials sorted by distance.
1
Northern Region
Luleå, Norrbotten County, Sweden, 901 87
2
Southern Region
Lund, Skåne County, Sweden, 221 00
3
Western Region
Gothenburg, Västra Götaland County, Sweden, 413 45
4
Southeast Region
Jönköping, Sweden, 581 85